Less than a quarter of patients diagnosed with mild psoriasis had a body surface area of less than 3% at the time of diagnosis.
Spain-based drugmaker REIG JOFRE has signed a commercial agreement with LEO Pharma, a privately-held Danish firm specializing ...
LEO Pharma and Reig Jofre have entered into a partnership aimed at improving access to LEO’s psoriasis treatment in Europe.
Turkey: A decade-long study from a tertiary care hospital highlights the effectiveness and safety of narrow-band ultraviolet ...
More training for community pharmacists to support easier access to healthcare Crisafulli Government extends training subsidy for ...
although Amgen is attempting to defend its product by expanding the label of the drug to include mild psoriasis. Last December, it secured FDA approval for the treatment of adult patients with ...
Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a recent Zacks Small-Cap Research repor ...
Both are once-a-day treatments ... add two more options for psoriasis patients hoping to stay away from biologics as long as they can. If symptoms remain mild to moderate, patients can stay ...
Robert Sidbury MD, MPH explored the “long list” of treatment options in atopic dermatitis and how the treatment landscape has changed as a result in a video interview with Healio.“So long list – I ...
OUR resident specialist and NHS GP, Dr Zoe Williams, shares her expert advice. Today, Dr Zoe helps a reader who is suffering ...
5don MSN
Both EMS and microcurrent technologies are widely popular in beauty tech devices suitable for at-home use. Some microcurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results